Hematology

During the Specialized Working Group session, ‘Quality of Life and Symptoms: Promoting Connection Between Patients and Clinicians’, which…

The most important advances in Ph-negative ALL come from the incorporation of immunotherapy into first-line ALL. In this sense…

THE 30th EUROPEAN Hematology Association (EHA) Congress marked a pivotal year in advancing the treatment and understanding…

THE EUROPEAN Hematology Association-European Medicines Agency (EHA2025-EMA) Joint Symposium on minimal residual disease (MRD)…

SINGLE clinical trial endpoints often fall short in capturing the full scope of patient experience, particularly in complex conditions…

My top priorities as EHA President align closely with the association’s strategic roadmap, which we have developed and begun to implement…

EHA offers an incredible wealth of opportunities; it’s actually quite difficult to choose which highlights to include. We are fortunate to…

THE 51st Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) was held this year in the vibrant city of…